CESPIATI, ANNALISA
 Distribuzione geografica
Continente #
NA - Nord America 3.184
AS - Asia 2.723
EU - Europa 2.098
SA - Sud America 290
Continente sconosciuto - Info sul continente non disponibili 192
AF - Africa 103
OC - Oceania 23
Totale 8.613
Nazione #
US - Stati Uniti d'America 3.023
IT - Italia 931
CN - Cina 789
SG - Singapore 660
VN - Vietnam 289
HK - Hong Kong 249
BR - Brasile 234
BD - Bangladesh 213
GB - Regno Unito 198
RU - Federazione Russa 152
DE - Germania 150
SE - Svezia 136
NL - Olanda 130
IN - India 121
FR - Francia 118
CA - Canada 86
KR - Corea 84
FI - Finlandia 60
ID - Indonesia 54
IE - Irlanda 53
JP - Giappone 47
TR - Turchia 47
EG - Egitto 41
MX - Messico 39
TW - Taiwan 36
CI - Costa d'Avorio 30
ES - Italia 30
PL - Polonia 25
AU - Australia 22
AT - Austria 19
IQ - Iraq 19
AR - Argentina 17
DK - Danimarca 16
UA - Ucraina 16
ZA - Sudafrica 15
CH - Svizzera 13
UZ - Uzbekistan 12
AE - Emirati Arabi Uniti 11
PH - Filippine 11
BE - Belgio 10
EC - Ecuador 10
SA - Arabia Saudita 10
PR - Porto Rico 9
TH - Thailandia 9
JO - Giordania 8
CO - Colombia 7
CR - Costa Rica 7
JM - Giamaica 7
NP - Nepal 7
PK - Pakistan 7
AZ - Azerbaigian 6
CL - Cile 6
LT - Lituania 6
MY - Malesia 6
IR - Iran 5
PT - Portogallo 5
BH - Bahrain 4
BY - Bielorussia 4
CZ - Repubblica Ceca 4
ET - Etiopia 4
PE - Perù 4
UY - Uruguay 4
VE - Venezuela 4
HN - Honduras 3
HU - Ungheria 3
KE - Kenya 3
KZ - Kazakistan 3
LU - Lussemburgo 3
TN - Tunisia 3
AL - Albania 2
BG - Bulgaria 2
BO - Bolivia 2
CM - Camerun 2
DZ - Algeria 2
GE - Georgia 2
GT - Guatemala 2
HR - Croazia 2
IL - Israele 2
LK - Sri Lanka 2
NI - Nicaragua 2
NO - Norvegia 2
PA - Panama 2
PS - Palestinian Territory 2
PY - Paraguay 2
RO - Romania 2
RS - Serbia 2
AI - Anguilla 1
AM - Armenia 1
BM - Bermuda 1
CY - Cipro 1
GR - Grecia 1
HT - Haiti 1
KG - Kirghizistan 1
KH - Cambogia 1
LB - Libano 1
MD - Moldavia 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
OM - Oman 1
QA - Qatar 1
Totale 8.415
Città #
Dallas 554
Ashburn 431
Singapore 373
Milan 196
Hong Kong 186
San Jose 172
Santa Clara 122
Los Angeles 114
Southend 111
Ho Chi Minh City 107
Hefei 103
Beijing 98
New York 94
Council Bluffs 90
Hanoi 69
Chandler 68
Boardman 62
Rome 62
Frankfurt am Main 53
Dublin 51
Guangzhou 46
Fairfield 40
Seoul 38
Toronto 36
Buffalo 35
Houston 35
Jakarta 35
Lauterbourg 35
Atlanta 34
Bengaluru 33
Moscow 33
Abidjan 30
Seattle 30
The Dalles 30
Chicago 29
Shanghai 28
São Paulo 28
Helsinki 27
Nanjing 27
Genoa 25
Wilmington 25
Munich 24
Princeton 24
Istanbul 23
Cairo 22
Ann Arbor 21
Bologna 21
Florence 21
Redwood City 21
Tokyo 21
Da Nang 20
Naples 18
Amsterdam 17
Columbus 17
Orem 17
Oxford 17
Mapo-gu 16
Paris 16
Phoenix 16
Turin 16
Warsaw 16
Denver 15
Lappeenranta 15
Montreal 15
San Francisco 15
Woodbridge 15
Boston 14
Cambridge 13
Changsha 13
Chennai 13
Hangzhou 13
Jinan 13
Nuremberg 13
Suzhou 13
Ankara 12
Kaohsiung 12
London 12
Palermo 12
Tashkent 12
Wuhan 12
Cangzhou 11
Brooklyn 10
Des Moines 10
Madrid 10
Piscataway 10
Tianjin 10
Washington 10
Baghdad 9
Falls Church 9
Grafing 9
Haiphong 9
Manchester 9
Mumbai 9
Stockholm 9
Turku 9
Amman 8
Chengdu 8
Dearborn 8
Melbourne 8
Memphis 8
Totale 4.614
Nome #
SARCOPENIA, LIVER AND CARDIOVASCULAR ALTERATIONS IN A MULTICENTRIC COHORT OF PATIENTS WITH MASLD: EVALUATION OF CLINICAL PRESENTATION AND GENETIC PREDISPOSITION 751
Prevalence and Risk Factors of Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Without Steatohepatitis 561
Statins, ACE/ARBs drug use, and risk of pneumonia in hospitalized older patients: a retrospective cohort study 482
Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver 398
Clinical characteristics and outcomes of vaccinated patients hospitalised with SARS-CoV-2 breakthrough infection: Multi-IPV, a multicentre study in Northern Italy 386
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both 365
PCSK7 gene variation bridges atherogenic dyslipidemia with hepatic inflammation in NAFLD patients 318
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 306
Prescription of ACE-Is/ARBs in patients with cardio-renal disease: a multicenter retrospective cohort study from the REPOSI registry 279
Underdiagnosis and undertreatment of osteoporotic patients admitted in internal medicine wards in Italy between 2010 and 2016 (the REPOSI Register) 267
Usefulness of fibrosis-4 (FIB-4) score and metabolic alterations in the prediction of SARS-CoV-2 severity 256
Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards : data from the RePoSI Registry 250
Interaction between lifestyle changes and PNPLA3 genotype in NAFLD patients during the COVID-19 lockdown 238
Clinical factors associated with death in 3044 COVID-19 patients managed in internal medicine wards in Italy : comment 217
Rare ATG7 genetic variants predispose patients to severe fatty liver disease 217
Anemia management and transfusion strategy in internal medicine units: Less is more 216
Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards : data from the RePoSI Registry 200
An Overview of Hepatocellular Carcinoma Surveillance Focusing on Non-Cirrhotic NAFLD Patients: A Challenge for Physicians 199
Impact of Sarcopenia and Myosteatosis in Non-Cirrhotic Stages of Liver Diseases: Similarities and Differences across Aetiologies and Possible Therapeutic Strategies 191
What Not to Overlook in the Management of Patients with Type 2 Diabetes Mellitus: The Nephrological and Hepatological Perspectives 175
Clinical risk scores for the early prediction of severe outocomes in patients hospitalized for {COVID}-19: comment 173
Portal hypertension-like pattern in coronavirus disease 2019 acute respiratory distress syndrome 164
Evolution of liver fibrosis in diabetic patients with NAFLD in a follow-up study: Hepatoprotective effects of sodium-glucose co-transporter-2 inhibitors 161
The multifaceted spectrum of liver cirrhosis in older hospitalised patients: analysis of the REPOSI registry 157
The I148M PNPLA3 variant mitigates niacin beneficial effects: How the genetic screening in non-alcoholic fatty liver disease patients gains value 153
The Negative Impact of Sarcopenia on Hepatocellular Carcinoma Treatment Outcomes 145
Prescription appropriateness of anti-diabetes drugs in elderly patients hospitalized in a clinical setting: evidence from the REPOSI Register 141
Metabolic factors drive early increase in hepatic steatosis despite improvement in non-invasive fibrosis markers after hepatitis C eradication with direct-acting antivirals 136
Procoagulant imbalance is associated with hepatic and vascular complications in patients with MASLD and diabetes. Key role of factor VIII 133
Metabolic comorbidities and male sex influence steatosis in chronic hepatitis C after viral eradication by direct-acting antiviral therapy (DAAs): Evaluation by the controlled attenuation parameter (CAP) 123
Effect of HCV eradication by DAAs on liver steatosis, carotid atherosclerosis, and associated metabolic comorbidities: A systematic review 123
MAFLD and NAFLD: is there the need for redefining the risk of cardiovascular disease and mortality? 120
Genetics and Epigenetics in the Clinic: Precision Medicine in the Management of Fatty Liver Disease 107
Nutritional and Lifestyle Therapy for NAFLD in People with HIV 106
Glomerular Hyperfiltration: A Marker of Fibrosis Severity in Metabolic Associated Steatotic Liver Disease in an Adult Population 100
Artificial intelligence as a ploy to delve into the intricate link between genetics and mitochondria in patients with MASLD 79
Subclinical and clinical atherosclerosis in non-alcoholic fatty liver disease is associated with the presence of hypertension 68
Prescribing cascades among hospitalized older adults: a retrospective cohort study from the REPOSI registry 61
Low lysosomal acid lipase activity is associated with histological progression of metabolic dysfunction-associated steatotic liver disease 47
Rare Atg7 Genetic Variants Predispose to Severe Fatty Liver Disease 44
Totale 8.613
Categoria #
all - tutte 22.268
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.268


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022300 0 25 22 20 37 29 15 22 43 18 20 49
2022/2023335 34 31 27 29 34 52 7 22 50 5 28 16
2023/2024370 13 25 20 26 82 19 20 11 31 24 38 61
2024/20251.715 70 156 58 137 125 86 139 149 109 209 204 273
2025/20264.738 365 597 642 395 302 196 542 246 334 292 382 445
2026/2027572 295 277 0 0 0 0 0 0 0 0 0 0
Totale 8.613